Switzerland· 60916001
Gilenya
A fingolimod product containing fingolimodum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 16 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Fingolimod is registered in 16 of 19 countries.
Countries holding a registration under ATC L04AE01 (fingolimod), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 9 of them publish a price we can compare per daily dose
Fingolimod · ATC L04AE01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of fingolimod costs, country by country.
Normalised to the WHO defined daily dose (0.5 mg), so markets compare like for like.
- Switzerland: $18.53 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Fingolimod · price per daily dose (0.5 mg)
USD · FX 28 Sept 2026
- IT Italy$27.25
- CH Switzerland$18.53
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- fingolimodum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- L04AE01
- ATC class
- Fingolimod
- Defined daily dose
- 0.5 mg, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768060916001028 StkCHF 942.35
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
584 interactions on record for fingolimod.
Graded by severity as the source publishes them — 503 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fingolimod · interactions on record
584 records
- 503 severe
- 77 moderate
- 4 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fingolimod in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaARELEPTANPharmaselect International Beteiligungs GmbH, Vídeň
- SpainFINGOLIMOD ACCORD 0,5 mg CAPSULAS DURAS EFGAccord Healthcare S.L.U.
- PolandAreleptanPharmaselect International Beteiligungs GmbH
- NetherlandsChantico 0,5 mg harde capsulesG.L. Pharma GmbH
- United StatesfingolimodGlenmark Pharmaceuticals Inc., USA
- FinlandAreleptanPharmaselect International Beteiligungs GmbH
- SwedenAreleptan 0,5 mg Kapsel, hårdPharmaselect International Beteiligungs GmbH
- United KingdomFingolimod 500microgram capsulesMSN Laboratories Europe Ltd
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Areleptan, Chantico
- Belgium · Fingolimod Ab, Fingolimod Eg
- Bulgaria · Chantico, Inzolfi
- Cyprus · Fingolimod Adelco, Fingolimod Remedica
- Czechia · Areleptan, Bonaxon
- Germany · Fingod, Fingolimod 123 Acurae Pharma
- Denmark · Areleptan, Bonaxon
- Estonia · Chantico, Efigalo
- Spain · Fingolimod, Fingolimod Aurovitas
- Finland · Fingolimod, Fingolimod Avansor
- France · Fingolimod Arrow, Fingolimod Benta
- United Kingdom (Northern Ireland) · Fingolimod, Fingolimod Amarox
- Greece · Fingolimod Adelco, Fingolimod Medochemie
- Croatia · Areleptan, Arlesias
- Hungary · Bonaxon, Chantico
- Ireland · Fingolimod Clonmel, Fingolimod Flynn Pharma
- Iceland · Fingolimod, Fingolimod Accord
- Italy · Fingolimod Aurobindo, Fingolimod Dr. Reddy’s
- Liechtenstein · Fingolimod Accord, Fingolimod Mylan
- Lithuania · Chantico, Efigalo
- Luxembourg · Fingolimod Eg, Fingolimod Ratiopharm
- Latvia · Bonaxon, Chantico
- Malta · Fingolimod Denk, Fingolimod Remedica
- Netherlands · Chantico, Fenoxa
- Norway · Areleptan, Fingolimod Accord
- Poland · Bonaxon, Chantico
- Portugal · Bluesar, Fingolimod Bluefish
- Romania · Fingolimod Dr. Reddys, Fingolimod Msn
- Sweden · Areleptan, Fingolimod Amarox
- Slovenia · Areleptan, Arlesias
- Slovakia · Areleptan, Bonaxon
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c1ed6904-b09e-4828-b972-bbf2b8d8e854 GET /v1/drugs/c1ed6904-b09e-4828-b972-bbf2b8d8e854?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "fingolimodum 0.5 mg",
"valid_from": "2011-07-15",
"limitations": "[{\"description\":\"Behandlung der schubförmig remittierenden multiplen Sklerose (MS) bei Erwachsenen. Erstverschreibung durch den Facharzt für Neurologie.\",\"costApproval\":null,\"indication\":null,\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2021-12-01\",\"validTo\":null}]",
"galenic_form": "Kaps 0.5 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2011-07-15",
"self_retention_pct": 40
}See everything about fingolimod.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.